Endo International Ordinary Shares reported $541.69M in Sales Revenues for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Abbvie ABBV:US USD 14.81B 229M
Amarin AMRN:US USD 89.88M 4.56M
Ani Pharmaceuticals ANIP:US USD 83.82M 9.97M
Bristol Myers Squibb BMY:US USD 11.22B 669M
Coherus Biosciences CHRS:US USD 45.42M 14.73M
Eli Lilly And LLY:US USD 6.94B 453.6M
Endo International Ordinary Shares ENDP:US USD 541.69M 27.42M
Heron Therapeutics HRTX:US USD 26.56M 1.07M
Hikma Pharmaceutical HIK:LN USD 1.21B 124M
Horizon Pharma HZNP:US USD 925.36M 48.95M
Lannett LCI:US USD 75.08M 890K
Ligand Pharmaceuticals LGND:US USD 62.51M 5.09M
Merk MRK:US USD 14.96B 366M
Novartis NOVN:VX USD 12.84B 243M
Pacira Pharmaceuticals PCRX:US USD 167.47M 1.94M
Patterson Companies PDCO:US USD 1.63B 102.94M
Perrigo Ordinary Shares PRGO:US USD 1.1B 21.5M
Pfizer PFE:US USD 24.29B 1.65B
Phibro Animal Health PAHC:US USD 232.52M 22.74M
Revance Therapeutics RVNC:US USD 29.01M 647K
Supernus Pharmaceuticals SUPN:US USD 177.35M 7.3M
Takeda 4502:JP JPY 1T 29.84B
Teva Pharmaceutical TEVA:IT USD 3.6B 191M
Xeris Pharmaceuticals Inc XERS:US USD 29.72M 4.42M
Zoetis ZTS:US USD 2B 50M